{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T14:59:46Z","timestamp":1792162786002,"version":"4.4.0"},"reference-count":44,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,9,23]],"date-time":"2024-09-23T00:00:00Z","timestamp":1727049600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Metabolic dysfunction-associated steatohepatitis (MASH) is characterized by persistent inflammatory cascades, with macrophage activation playing a pivotal role. Chitinase 1 (CHIT1), produced by activated macrophages, is a key player in this cascade. In this study, we aimed to explore the role of CHIT1 in MASH with progressive liver fibrosis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Fibrotic liver tissue and serum from distinct patient groups were analyzed using nCounter MAX, flow cytometry, immunohistochemistry, and enzyme-linked immunosorbent assay. A MASH mouse model was constructed to evaluate the effectiveness of OATD-01, a chitinase inhibitor. Macrophage profiling was performed using single-nuclei RNA sequencing and flow cytometry.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>CHIT1 expression in fibrotic liver tissues was significantly correlated with the extent of liver fibrosis, macrophages, and inflammation. Single-nuclei RNA sequencing demonstrated a notable increase in macrophages numbers, particularly of lipid-associated macrophages, in MASH mice. Treatment with OATD-01 reduced non-alcoholic fatty liver disease activity score and Sirius red-positive area. Additionally, OATD-01-treated mice had lower CHIT1, F4\/80, and \u03b1-smooth muscle actin positivity, as well as significantly lower levels of inflammatory markers, pro-fibrotic genes, and matrix remodeling-related mRNAs than vehicle-treated mice. Although the population of F4\/80<jats:sup>+<\/jats:sup>CD11b<jats:sup>+<\/jats:sup> intrahepatic mononuclear phagocytes remained unchanged, their infiltration and activation (CHIT1<jats:sup>+<\/jats:sup>MerTK<jats:sup>+<\/jats:sup>) significantly decreased in OATD-01-treated mice, compared with that observed in vehicle-treated mice.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Our study underscores the pivotal role of CHIT1 in MASH. The observed significant improvement in inflammation and hepatic fibrosis, particularly at higher doses of the CHIT1 inhibitor, strongly suggests the potential of CHIT1 as a therapeutic target in MASH accompanied by progressive liver fibrosis.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2024.1444100","type":"journal-article","created":{"date-parts":[[2024,9,23]],"date-time":"2024-09-23T04:26:57Z","timestamp":1727065617000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Chitinase 1: a novel therapeutic target in metabolic dysfunction-associated steatohepatitis"],"prefix":"10.3389","volume":"15","author":[{"given":"Jung Hoon","family":"Cha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na Ri","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung Woo","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heechul","family":"Nam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun Sun","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeong Won","family":"Jang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong Young","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung Kew","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pil Soo","family":"Sung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si Hyun","family":"Bae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,9,23]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2023-330595","article-title":"Masld: A systemic metabolic disorder with cardiovascular and Malignant complications","volume":"73","author":"Targher","year":"2024","journal-title":"Gut"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3350\/cmh.2023.0449","article-title":"Identification of signature gene set as highly accurate determination of masld progression","volume":"30","author":"Oh","year":"2024","journal-title":"Clin Mol Hepatol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2023.03.041","article-title":"Clinical trial landscape in nash","volume":"21","author":"Harrison","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1056\/NEJMoa2309000","article-title":"A phase 3, randomized, controlled trial of resmetirom in nash with liver fibrosis","volume":"390","author":"Harrison","year":"2024","journal-title":"N Engl J Med"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-018-0082-x","article-title":"The role of macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis","volume":"16","author":"Kazankov","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1038\/s41574-022-00675-6","article-title":"Macrophage functional diversity in nafld - more than inflammation","volume":"18","author":"Barreby","year":"2022","journal-title":"Nat Rev Endocrinol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3390\/cells11213387","article-title":"Multiplexed digital spatial protein profiling reveals distinct phenotypes of mononuclear phagocytes in livers with advanced fibrosis","volume":"11","author":"Lee","year":"2022","journal-title":"Cells"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3350\/cmh.2021.0308","article-title":"Crosstalk between tumor-associated macrophages and neighboring cells in hepatocellular carcinoma","volume":"28","author":"Sung","year":"2022","journal-title":"Clin Mol Hepatol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.jhepr.2019.02.004","article-title":"Macrophages in obesity and non-alcoholic fatty liver disease: crosstalk with metabolism","volume":"1","author":"Lefere","year":"2019","journal-title":"JHEP Rep"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1002\/hep.31056","article-title":"Increased liver localization of lipopolysaccharides in human and experimental nafld","volume":"72","author":"Carpino","year":"2020","journal-title":"Hepatology"},{"key":"B11","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1016\/j.molcel.2019.07.028","article-title":"Landscape of intercellular crosstalk in healthy and nash liver revealed by single-cell secretome gene analysis","volume":"75","author":"Xiong","year":"2019","journal-title":"Mol Cell"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2019-318382","article-title":"Myeloid cells in liver and bone marrow acquire a functionally distinct inflammatory phenotype during obesity-related steatohepatitis","volume":"69","author":"Krenkel","year":"2020","journal-title":"Gut"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2023.03.038","article-title":"An integrated view of anti-inflammatory and antifibrotic targets for the treatment of nash","volume":"79","author":"Tacke","year":"2023","journal-title":"J Hepatol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2005.075697","article-title":"Chitotriosidase gene expression in kupffer cells from patients with non-alcoholic fatty liver disease","volume":"55","author":"Malaguarnera","year":"2006","journal-title":"Gut"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2006.00680.x","article-title":"Potential role of chitotriosidase gene in nonalcoholic fatty liver disease evolution","volume":"101","author":"Malaguarnera","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1515\/CCLM.2005.088","article-title":"Effect of interferon-gamma, interleukin-10, lipopolysaccharide and tumor necrosis factor-alpha on chitotriosidase synthesis in human macrophages","volume":"43","author":"Di Rosa","year":"2005","journal-title":"Clin Chem Lab Med"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10010180","article-title":"A unique immune-related gene signature represents advanced liver fibrosis and reveals potential therapeutic targets","volume":"10","author":"Sung","year":"2022","journal-title":"Biomedicines"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2029349","article-title":"Prospective study of outcomes in adults with nonalcoholic fatty liver disease","volume":"385","author":"Sanyal","year":"2021","journal-title":"N Engl J Med"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1007\/s10238-022-00799-z","article-title":"Liver biopsy for assessment of chronic liver diseases: A synopsis","volume":"23","author":"Chowdhury","year":"2023","journal-title":"Clin Exp Med"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3343\/alm.2018.38.4.348","article-title":"Diagnosis of liver fibrosis with wisteria floribunda agglutinin-positive mac-2 binding protein (Wfa-M2bp) among chronic hepatitis B patients","volume":"38","author":"Jekarl","year":"2018","journal-title":"Ann Lab Med"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.113952","article-title":"Tenofovir alafenamide alleviates nonalcoholic steatohepatitis in mice by blocking the phosphorylation of akt in intrahepatic mononuclear phagocytes","volume":"156","author":"Roh","year":"2022","journal-title":"BioMed Pharmacother"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2022.174792","article-title":"Inhibition of chit1 as a novel therapeutic approach in idiopathic pulmonary fibrosis","volume":"919","author":"Sklepkiewicz","year":"2022","journal-title":"Eur J Pharmacol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2015.10.016","article-title":"Mertk rs4374383 polymorphism affects the severity of fibrosis in non-alcoholic fatty liver disease","volume":"64","author":"Petta","year":"2016","journal-title":"J Hepatol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1631-3","article-title":"Resolving the fibrotic niche of human liver cirrhosis at single-cell level","volume":"575","author":"Ramachandran","year":"2019","journal-title":"Nature"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2022.e11135","article-title":"Mir-23b-3p suppresses epithelial-mesenchymal transition, migration, and invasion of hepatocellular carcinoma cells by targeting C-met","volume":"8","author":"Park","year":"2022","journal-title":"Heliyon"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-018-0276-y","article-title":"Reference-based analysis of lung single-cell sequencing reveals a transitional profibrotic macrophage","volume":"20","author":"Aran","year":"2019","journal-title":"Nat Immunol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1038\/s41467-022-28803-w","article-title":"Fully-automated and ultra-fast cell-type identification using specific marker combinations from single-cell transcriptomic data","volume":"13","author":"Ianevski","year":"2022","journal-title":"Nat Commun"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.171701","article-title":"A lipid-associated macrophage lineage rewires the spatial landscape of adipose tissue in early obesity","volume":"8","author":"Stansbury","year":"2023","journal-title":"JCI Insight"},{"key":"B29","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1016\/j.cell.2019.05.054","article-title":"Lipid-associated macrophages control metabolic homeostasis in a trem2-dependent manner","volume":"178","author":"Jaitin","year":"2019","journal-title":"Cell"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1007\/978-981-13-7318-3_11","article-title":"Human chitinases: structure, function, and inhibitor discovery","volume":"1142","author":"Kumar","year":"2019","journal-title":"Adv Exp Med Biol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-020-00572-w","article-title":"Immunobiology and immunotherapy of hcc: spotlight on innate and innate-like immune cells","volume":"18","author":"Ruf","year":"2021","journal-title":"Cell Mol Immunol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioteChadv.2020.107553","article-title":"Glycoside hydrolase family 18 chitinases: the known and the unknown","volume":"43","author":"Chen","year":"2020","journal-title":"Biotechnol Adv"},{"key":"B33","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.cmet.2019.11.013","article-title":"Macrophage mertk promotes liver fibrosis in nonalcoholic steatohepatitis","volume":"31","author":"Cai","year":"2020","journal-title":"Cell Metab"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2022.100444","article-title":"Macrophage mertk promotes profibrogenic cross-talk with hepatic stellate cells via soluble mediators","volume":"4","author":"Pastore","year":"2022","journal-title":"JHEP Rep"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.26508\/lsa.201900350","article-title":"Chitinase 1 regulates pulmonary fibrosis by modulating tgf-beta\/smad7 pathway via tgfbrap1 and foxo3","volume":"2","author":"Lee","year":"2019","journal-title":"Life Sci Alliance"},{"key":"B36","doi-asserted-by":"publisher","first-page":"46","DOI":"10.2174\/1872213x14666200114184054","article-title":"Chitinases: therapeutic scaffolds for allergy and inflammation","volume":"14","author":"Madan","year":"2020","journal-title":"Recent Pat Inflammation Allergy Drug Discovery"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1038\/ja.2006.57","article-title":"Chitinase inhibitor allosamidin is a signal molecule for chitinase production in its producing streptomyces I. Analysis of the chitinase whose production is promoted by allosamidin and growth accelerating activity of allosamidin","volume":"59","author":"Suzuki","year":"2006","journal-title":"J Antibiot (Tokyo)"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M310057200","article-title":"Interactions of a family 18 chitinase with the designed inhibitor hm508 and its degradation product, chitobiono-delta-lactone","volume":"279","author":"Vaaje-Kolstad","year":"2004","journal-title":"J Biol Chem"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1021\/jm049940a","article-title":"Structure-based exploration of cyclic dipeptide chitinase inhibitors","volume":"47","author":"Houston","year":"2004","journal-title":"J Med Chem"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2023.117172","article-title":"Discovery of aromatic 2-(3-(Methylcarbamoyl) guanidino)-N-aylacetamides as highly potent chitinase inhibitors","volume":"80","author":"Zhao","year":"2023","journal-title":"Bioorg Med Chem"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2023.122163","article-title":"Effects of chitinase-1 inhibitor in obesity-induced and -aggravated asthma in a murine model","volume":"334","author":"Han","year":"2023","journal-title":"Life Sci"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.0c01179","article-title":"Discovery of oatd-01, a first-in-class chitinase inhibitor as potential new therapeutics for idiopathic pulmonary fibrosis","volume":"63","author":"Koralewski","year":"2020","journal-title":"J Med Chem"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24054719","article-title":"Inhibition of macrophage-specific chit1 as an approach to treat airway remodeling in severe asthma","volume":"24","author":"Sklepkiewicz","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmgh.2020.07.012","article-title":"Single-nuclei rna sequencing assessment of the hepatic effects of 2,3,7,8-tetrachlorodibenzo-P-dioxin","volume":"11","author":"Nault","year":"2021","journal-title":"Cell Mol Gastroenterol Hepatol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1444100\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,23]],"date-time":"2024-09-23T04:27:00Z","timestamp":1727065620000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1444100\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,23]]},"references-count":44,"alternative-id":["10.3389\/fimmu.2024.1444100"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2024.1444100","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,23]]},"article-number":"1444100"}}